{"entity":{"type":"insider","cik":"0001656151","url":"/insider/0001656151","json_url":"/insider/0001656151.json","name":"Shanafelt Armen","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2016-08-16","last":"2021-12-13","span_basis":"filed_date"},"name_variants":[{"name":"Shanafelt Armen","source":"filing","n_filings":4,"first_seen":"2016-08-16","last_seen":"2021-12-13"}],"transactions":[{"id":4849477,"accession":"0001209191-21-069351","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-069351","line_url":"/filing/0001209191-21-069351#line-3","is_derivative":false,"issuer_cik":"0001636282","issuer_name":"Aeglea BioTherapeutics, Inc.","issuer_ticker":"AGLE","issuer_name_source":null,"issuer_url":"/issuer/0001636282","owner_cik":"0001656151","owner_name":"Shanafelt Armen","owner_display_name":"Shanafelt Armen","owner_url":"/insider/0001656151","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14685.0,"shares_display":"14,685","price_per_share":3.65,"price_display":"3.65","price_state":"stated","total_value":53600.25,"total_display":"53,600.25","total_whole":"53,600","shares_owned_after":150000.0,"shares_owned_after_display":"150,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-13","filed_date":"2021-12-13","scope":"insider"},{"id":4849472,"accession":"0001209191-21-069351","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-069351","line_url":"/filing/0001209191-21-069351#line-2","is_derivative":false,"issuer_cik":"0001636282","issuer_name":"Aeglea BioTherapeutics, Inc.","issuer_ticker":"AGLE","issuer_name_source":null,"issuer_url":"/issuer/0001636282","owner_cik":"0001656151","owner_name":"Shanafelt Armen","owner_display_name":"Shanafelt Armen","owner_url":"/insider/0001656151","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13516.0,"shares_display":"13,516","price_per_share":3.65,"price_display":"3.65","price_state":"stated","total_value":49333.4,"total_display":"49,333.40","total_whole":"49,333","shares_owned_after":135315.0,"shares_owned_after_display":"135,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-13","scope":"insider"},{"id":4849465,"accession":"0001209191-21-069351","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-069351","line_url":"/filing/0001209191-21-069351#line-1","is_derivative":false,"issuer_cik":"0001636282","issuer_name":"Aeglea BioTherapeutics, Inc.","issuer_ticker":"AGLE","issuer_name_source":null,"issuer_url":"/issuer/0001636282","owner_cik":"0001656151","owner_name":"Shanafelt Armen","owner_display_name":"Shanafelt Armen","owner_url":"/insider/0001656151","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":121799.0,"shares_display":"121,799","price_per_share":3.668,"price_display":"3.67","price_state":"stated","total_value":446758.732,"total_display":"446,758.73","total_whole":"446,759","shares_owned_after":121799.0,"shares_owned_after_display":"121,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-09","filed_date":"2021-12-13","scope":"insider"},{"id":6604642,"accession":"0001209191-18-025823","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-025823","line_url":"/filing/0001209191-18-025823#line-2","is_derivative":false,"issuer_cik":"0001656151","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001656151","owner_cik":"0001656151","owner_name":"Shanafelt Armen","owner_display_name":"Shanafelt Armen","owner_url":"/insider/0001656151","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":266000.0,"shares_display":"266,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":3990000.0,"total_display":"3,990,000.00","total_whole":"3,990,000","shares_owned_after":3447817.0,"shares_owned_after_display":"3,447,817","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-23","filed_date":"2018-04-23","scope":"insider"},{"id":5237319,"accession":"0000899243-17-018096","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-018096","line_url":"/filing/0000899243-17-018096#line-2","is_derivative":false,"issuer_cik":"0001420565","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001420565","owner_cik":"0001656151","owner_name":"Shanafelt Armen","owner_display_name":"Shanafelt Armen","owner_url":"/insider/0001656151","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":3750000.0,"total_display":"3,750,000.00","total_whole":"3,750,000","shares_owned_after":1094987.0,"shares_owned_after_display":"1,094,987","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-07-05","filed_date":"2017-07-07","scope":"insider"},{"id":2739884,"accession":"0001209191-16-137315","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-137315","line_url":"/filing/0001209191-16-137315#line-4","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001656151","owner_name":"Shanafelt Armen","owner_display_name":"Shanafelt Armen","owner_url":"/insider/0001656151","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":583333.0,"shares_display":"583,333","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":6999996.0,"total_display":"6,999,996.00","total_whole":"6,999,996","shares_owned_after":2099482.0,"shares_owned_after_display":"2,099,482","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-16","filed_date":"2016-08-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001636282","name":"Aeglea BioTherapeutics, Inc.","url":"/issuer/0001636282","role":"Director","n_filings":1,"first_seen":"2021-12-13","last_seen":"2021-12-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001718108","name":"Surface Oncology, Inc.","url":"/issuer/0001718108","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2018-04-23","last_seen":"2018-04-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001420565","name":"AILERON THERAPEUTICS INC","url":"/issuer/0001420565","role":"Director","n_filings":1,"first_seen":"2017-07-07","last_seen":"2017-07-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001377121","name":"Protagonist Therapeutics, Inc","url":"/issuer/0001377121","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2016-08-16","last_seen":"2016-08-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001656151","retrieved_at":"2026-08-26T22:20:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}